Addiction psychiatry

Rittenhouse Psychiatric Associates Hires Samantha Wyckoff, MD as Director of Addiction Services - Solidifying Focus on a Healthier Philadelphia

Retrieved on: 
Thursday, March 7, 2024
Rittenhouse Square, MAT, MD, Medical director, Friends, Neurology, Addiction psychiatry, Montefiore Medical Center, Anxiety, Diagnosis, Psychiatry, Opioid epidemic, Weill Cornell Medical Center, Nursing

PHILADELPHIA, March 7, 2024 /PRNewswire/ -- In a major move to support Philadelphians toward a healthier future, Rittenhouse Psychiatric Associates— one of the city's largest outpatient mental health practices— has announced the hire of Samantha Wyckoff, MD as their Director of Addiction Services.

Key Points: 
  • PHILADELPHIA, March 7, 2024 /PRNewswire/ -- In a major move to support Philadelphians toward a healthier future, Rittenhouse Psychiatric Associates— one of the city's largest outpatient mental health practices— has announced the hire of Samantha Wyckoff, MD as their Director of Addiction Services.
  • "I am joining Rittenhouse Psychiatric Associates at a critical time for our communities in Philadelphia," said Wyckoff.
  • Dr. Chris Pagnani, MD, Rittenhouse Psychiatric Associates' Founder and Medical Director, added, "Major efforts are being made by Mayor Parker's administration to tackle the opioid epidemic in Philadelphia.
  • Dr. Wyckoff offers substance use disorder services at Rittenhouse Psychiatric Associate's Rittenhouse Square office in Philadelphia and via telepsychiatry to all of Pennsylvania.

Personality predicting relapse: A facet analysis of the NEO PI‐R - A recent study published in The American Journal on Addictions

Retrieved on: 
Friday, January 5, 2024
Psychiatry, NEO, Competence, American Journal, Risk, Addiction, Conscientiousness, Research, Medical director, Doctor of Philosophy, AAAP, Personality, American Academy, Behavioural sciences, Addiction psychiatry, Feinberg School of Medicine, Pharmaceutical industry

This study provides an in-depth analysis of the individual facets of the NEO PI-R (personality assessment test) domains and their association with substance use disorders.

Key Points: 
  • This study provides an in-depth analysis of the individual facets of the NEO PI-R (personality assessment test) domains and their association with substance use disorders.
  • The research provides insight into the nuances of potential relapse and how personality traits may provide valuable information to treatment providers and individuals alike.
  • "Making a continued effort to study outcomes is essential for continued quality improvement for any addiction program.
  • Having consistent predictive measures such as personality inventories can inform treatment planning and interventions that can assist at improving outcomes.

Digital Health Startup CARI Health Establishes Advisory Board

Retrieved on: 
Thursday, November 9, 2023
Wearables, Mobile Technology, Technology, Mental Health, Medical Devices, Health Technology, Professional Services, Start-Up, Health, Pharmaceutical, Johns Hopkins University, Medicine, Psychiatry, Addiction psychiatry, Methadone, Patient, Coronavirus Scientific Advisory Board, Digital, CARI, Behavioural sciences, MD, Advisory board, UCSD, Medical device, Dentistry, Pharmaceutical industry

Digital health company CARI Health forms Advisory Board to support development of its wearable remote medication monitoring device .

Key Points: 
  • Digital health company CARI Health forms Advisory Board to support development of its wearable remote medication monitoring device .
  • CARI Health intends to enable clinicians to view patient medication levels remotely in real time, ensuring correct dosages of prescribed medications.
  • “We are honored to have these outstanding professionals on the CARI Health Advisory Board.
  • CARI Health Advisory Board members include:
    Carla Marienfeld, MD, DFAPA, FASAM, board-certified, psychiatry, addiction psychiatry and addition medicine; Clinical Professor, UCSD
    Ken Stoller, MD, Professor of Clinical Psychiatry and Behavioral Sciences at Johns Hopkins University; Medical Director Behavioral Health for Johns Hopkins Health Plan
    “The promise of methadone patients being able to demonstrate compliance remotely, without daily clinic visits, is what attracted me to CARI Health,” said Patient Advocate Brenda Davis.

Top Ten Things Physicians and the Public Should Know about Addiction; Resources Developed by Medical Associations Released Today

Retrieved on: 
Thursday, November 2, 2023
Policy, ASAM, American Psychiatric Association, AAFP, Physician, APA, Psychiatry, Research, Addiction psychiatry, American Academy, DSM-IV codes, American Academy of Addiction Psychiatry, Family, Addiction, Addiction medicine, Patient, Diagnosis, Pharmaceutical industry

The APA’s vision is to ensure access to quality psychiatric diagnosis and treatment.

Key Points: 
  • The APA’s vision is to ensure access to quality psychiatric diagnosis and treatment.
  • Family physicians conduct approximately one in five office visits -- that’s 192 million visits annually or 48 percent more than the next most visited medical specialty.
  • Today, family physicians provide more care for America’s underserved and rural populations than any other medical specialty.
  • ASAM, founded in 1954, is a professional medical society representing over 7,000 physicians, clinicians and associated professionals in the field of addiction medicine.

Eliza Dushku Palandjian and Peter Palandjian Honored at Brigham and Women’s Hospital in Boston

Retrieved on: 
Tuesday, August 1, 2023
Mental Health, Women, Hospitals, Entertainment, Philanthropy, Celebrity, Health, Consumer, Other Philanthropy, Partnership, Addiction psychiatry, Education, MSHA, Intercontinental Real Estate Corporation, Multimedia, Research, Addiction medicine, Patient, Nursing, Division, Mass, Mass General Brigham, Growth, Hospital, Management, Pharmaceutical industry, Brigham, MD

Eliza Dushku Palandjian and husband Peter Palandjian were honored at Brigham and Women’s Hospital , with the renowned Boston-based hospital naming the Eliza Dushku Palandjian and Peter Palandjian Bridge Clinic in their honor.

Key Points: 
  • Eliza Dushku Palandjian and husband Peter Palandjian were honored at Brigham and Women’s Hospital , with the renowned Boston-based hospital naming the Eliza Dushku Palandjian and Peter Palandjian Bridge Clinic in their honor.
  • Higgins, MD, MSHA, President, Brigham and Women’s Hospital and Executive Vice President, Mass General Brigham; Samata Sharma, MD, Medical Director, Eliza Dushku Palandjian and Peter Palandjian Bridge Clinic; Joji Suzuki, MD, Director, Division of Addiction Psychiatry and Program Director, Addiction Medicine Fellowship Program; Eliza Dushku Palandjian; Peter Palandjian.
  • To recognize Eliza and Peter’s generosity, the Brigham named the Eliza Dushku Palandjian and Peter Palandjian Bridge Clinic.
  • Higgins, MD, MSHA, president of Brigham and Women’s Hospital and executive vice president at Mass General Brigham.

Apply Now for the Dr. Charles Noplis Scholarship, a Game-Changer for Medical Students

Retrieved on: 
Thursday, April 13, 2023
American Psychiatric Association, Addiction psychiatry, University, American Academy, Medicine, American Society of Addiction Medicine, Creativity, Addiction medicine, University of Louisville School of Medicine, Essay, Student, Patient, Health, American Academy of Addiction Psychiatry, Society, Nursing, Science, Psychiatry, Biology

LOUISVILLE, Ky., April 13, 2023 /PRNewswire/ -- The Dr. Charles Noplis Scholarship for Medical Students is a new opportunity for aspiring medical professionals in the United States.

Key Points: 
  • LOUISVILLE, Ky., April 13, 2023 /PRNewswire/ -- The Dr. Charles Noplis Scholarship for Medical Students is a new opportunity for aspiring medical professionals in the United States.
  • This scholarship was created by Dr. Charles Noplis, a highly skilled psychiatrist with more than ten years of experience in the field.
  • With a passion for helping others, Dr. Charles Noplis created the scholarship to support students who are currently enrolled in a university or high school students who plan to pursue a medical degree.
  • In summary, the Dr. Charles Noplis Scholarship for Medical Students is an excellent opportunity for students who are passionate about pursuing a medical degree.

AWARE RECOVERY CARE ANNOUNCES NEW CHIEF MEDICAL OFFICER

Retrieved on: 
Tuesday, April 11, 2023
Kaiser Permanente, Medical Affairs Bureau, Addiction psychiatry, Medical University of South Carolina, Education, Opioid use disorder, Lead, Medical school, Private practice, CMO, Organization, Penn State College of Information Sciences and Technology, MD, Patient, Penn State University College of Medicine, National Mental Health Act, Health, Factitious disorder, Pharmaceutical industry, Nursing, Addiction, Psychiatry

WALLINGFORD, Conn., April 11, 2023 /PRNewswire/ -- Aware Recovery Care, a pioneer in the in-home mental health and substance use disorder treatment industry, announced today that it has appointed Lauren H. Grawert, MD, as the company's new Chief Medical Officer (CMO).

Key Points: 
  • WALLINGFORD, Conn., April 11, 2023 /PRNewswire/ -- Aware Recovery Care, a pioneer in the in-home mental health and substance use disorder treatment industry, announced today that it has appointed Lauren H. Grawert, MD, as the company's new Chief Medical Officer (CMO).
  • She received her medical and psychiatric residency training, and addiction fellowship completion, at Medical University of South Carolina.
  • "Dr. Grawert brings broad and deep experience as both a medical doctor and an accomplished leader in the field, and I'm delighted to have her join the Aware Recovery Care team," said Dr. Holzer.
  • I look forward to helping Aware uphold best-in-class addiction care for the patients that need us."

NRMP® Publishes Comprehensive Data Book for Fellowship Matches

Retrieved on: 
Wednesday, April 5, 2023
Adolescent medicine, Pain management, Addiction psychiatry, Sports medicine, Metabolism, Addiction, Critical Care Medicine (journal), Urogynecology, Cardiovascular disease, Gynecologic Oncology (journal), American Board of Colon and Rectal Surgery, MBA, BSN, Medical specialty, Addiction medicine, National Resident Matching Program, NRMP, Colon, MD, Physician, Doctor of Health Science, Sleep medicine, IMG, Diabetes, Anne Ferguson-Smith, Medical genetics, SMS, Medicine, Nursing, Dentistry, Health insurance, Nephrology, Endocrinology, Match

WASHINGTON, April 5, 2023 /PRNewswire/ -- The National Resident Matching Program® (NRMP) has released Results and Data Specialties Matching Service, 2023 Appointment Year for Fellowship Matches conducted by the NRMP's Specialties Matching Service (SMS®). The report shows 13,919 active applicants competed for 13,365 fellowship positions offered by 5,734 programs. 

Key Points: 
  • The NRMP formalized its Specialties Matching Service in 1984 and conducted its first fellowship Match that year for Colon & Rectal Surgery.
  • Currently, the Specialties Matching Service has grown to include 73 subspecialties in 20 separate fellowship Matches occurring year-round.
  • The number of fellowship positions per active U.S. MD graduate was 1.83 for the 2023 appointment year, 0.07 more than last year.
  • The ratio of fellowship positions to all active applicants was 0.96 for the 2023 appointment year, 0.03 more than last year.

Pear Therapeutics Presents Real-World Clinical Data Assessing Engagement and Abstinence in Patients with Alcohol Use Disorders Using reSET® at AAAP

Retrieved on: 
Thursday, December 15, 2022
Technology, Research, FDA, Software, Biotechnology, Health, Pharmaceutical, Data Management, Science, Cognitive behavioral therapy, Substance use disorder, Patient, United, Insomnia, United States $1 Coin Act of 1997, Opioid use disorder, FDA, Suicidal ideation, AUD, Reading, Addiction psychiatry, Reset, Policy by press release, Public, PDT, SAMHSA, PEAR, Cannabis, SUD, MD, Pear, Language isolate, MBA, Smartphone, Centers for Disease Control and Prevention, Cocaine, Therapy, Risk, Public health, Pharmaceutical industry, Birth control, Hospital, Health

The real-world observational study evaluated 548 patients with alcohol-related disorders from 28 states who were treated with reSET over 12 weeks.

Key Points: 
  • The real-world observational study evaluated 548 patients with alcohol-related disorders from 28 states who were treated with reSET over 12 weeks.
  • The primary endpoint was engagement with reSET (lessons completed) throughout the prescription, and activity was also assessed as any use of reSET during a given week.
  • These data highlight benefits from reSET, which is indicated to treat addiction to cannabis, cocaine, and stimulants and alcohol when used with another substance.
  • A prescription digital therapeutic for substance use disorder: real-world engagement and abstinence patterns in patients diagnosed with alcohol-related disorders.

Imbrium Therapeutics Presents Results of a Phase 2 Study of Sunobinop at 33rd American Academy of Addiction Psychiatry Annual Meeting

Retrieved on: 
Monday, December 12, 2022
Science, Biotechnology, Research, Pharmaceutical, Health, FDA, Mental Health, Clinical Trials, Crave, Doctor of Pharmacy, Sleep, Maintenance, Therapy, Interstitial, Physician, M.A, AAAP, Addiction psychiatry, Conditional sentence, Polysomnography, AUD, Central nervous system, Eileen Brooke, American Academy, PSG, Patient, Prevalence, Somnolence, Alcoholism, Architecture, FDA, Peripheral nervous system, Pain, CI, Wakefulness, Journal of Medicinal Chemistry, NOP, PACS, LSM, Safety, Gene–environment correlation, Preclinical development, Overactive bladder, Anxiety, American Academy of Addiction Psychiatry, Kolla, Pharmaceutical industry, Mare Imbrium, Insomnia

The data were presented in a poster presentation (#76) at the 33rd Annual Meeting and Scientific Symposium of the American Academy of Addiction Psychiatry (AAAP).

Key Points: 
  • The data were presented in a poster presentation (#76) at the 33rd Annual Meeting and Scientific Symposium of the American Academy of Addiction Psychiatry (AAAP).
  • Sunobinop is an internally discovered oral compound being evaluated as a potential treatment for multiple disorders including insomnia during recovery from AUD.
  • The Phase 2 randomized, double-blind, multi-center, placebo-controlled, parallel-group clinical study enrolled 114 people experiencing insomnia during recovery from AUD.
  • Imbrium is a clinical-stage biopharmaceutical company dedicated to advancing medical science through the development of important new pharmacologic and biologic therapeutics.